Mourant

11th Annual IBA World Life Sciences Conference

11 Jun - 13 Jun 2025

Session information

Roundtable discussion and summaries

Description

Navigating the intersection of patent strategies and antitrust regulations in the pharmaceutical industry: Lessons from the Teva Copaxone Case and other national decisions.

Discuss Teva Copaxone case by European Commission - generic and innovator perspectives on competition law and IP - European and US status regarding divisional patent applications - Sham Litigation as an Anticompetitive Behaviour.